Compounds > 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine
Page last updated: 2024-09-03

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Cancer of Pituitary

2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, BS; Chen, CT; Hsu, TI; Huang, MH; Kang, YF; Shen, AY; Wang, TS; Wu, HM; Wu, SN1

Other Studies

1 other study(ies) available for 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and Cancer of Pituitary

ArticleYear
Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH₃ pituitary tumor cells.
    Toxicology, 2011, Feb-04, Volume: 280, Issue:1-2

    Topics: Animals; Cell Line, Tumor; Ether-A-Go-Go Potassium Channels; Methadone; Naloxone; Narcotics; Neurons; Pituitary Neoplasms; Prolactin; Pyrrolidines; Rats; Risperidone

2011